Literature DB >> 27149915

Tumor suppressive actions of the nuclear receptor corepressor 1.

Olaia Martínez-Iglesias1, Elvira Alonso-Merino1, Ana Aranda2.   

Abstract

Nuclear Receptor Corepressor 1 (NCoR) is an important transcriptional regulator that interacts with nuclear receptors and other transcription factors. Recent results have shown the presence of inactivating mutations or deletions of the NCoR gene in human tumors. NCoR has a strong tumor suppressor activity, inhibiting invasion, metastasis formation and tumor growth in xenograft mouse models. These changes are associated to transcriptional inhibition of genes linked to bad prognosis and increased metastasis in cancer patients. NCoR loss causes a long-term repression of NCoR gene transcription, suggesting that NCoR deficiency in the cancer cell could be propagated playing a role in tumor progression in the absence of NCoR gene mutations. The thyroid hormone receptor TRβ increases NCoR expression and this induction is essential in mediating the anti-metastatic and tumor suppressive actions of the receptor. Since metastasis is the main cause of cancer-related deaths, these results define NCoR as a potential target for cancer therapy.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Gene transcription; Metastasis; Nuclear receptor corepressor 1

Mesh:

Substances:

Year:  2016        PMID: 27149915     DOI: 10.1016/j.phrs.2016.04.027

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  4 in total

Review 1.  Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.

Authors:  Stéphanie Légaré; Mark Basik
Journal:  Mol Endocrinol       Date:  2016-07-20

2.  Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study.

Authors:  Francesco Cianflone; Dejan Lazarevic; Anna Palmisano; Giuseppe Fallara; Alessandro Larcher; Massimo Freschi; Giacomo Dell'Antonio; Giulia Maria Scotti; Marco J Morelli; Anna Maria Ferrara; Francesco Trevisani; Alessandra Cinque; Antonio Esposito; Alberto Briganti; Carlo Tacchetti; Claudio Doglioni; Alessandro Del Maschio; Francesco de Cobelli; Roberto Bertini; Andrea Salonia; Francesco Montorsi; Giovanni Tonon; Umberto Capitanio
Journal:  Transl Androl Urol       Date:  2022-02

3.  Thyroid Hormone Receptor β Suppression of RUNX2 Is Mediated by Brahma-Related Gene 1-Dependent Chromatin Remodeling.

Authors:  Noelle E Gillis; Thomas H Taber; Eric L Bolf; Caitlin M Beaudet; Jennifer A Tomczak; Jeffrey H White; Janet L Stein; Gary S Stein; Jane B Lian; Seth Frietze; Frances E Carr
Journal:  Endocrinology       Date:  2018-06-01       Impact factor: 4.736

4.  Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene.

Authors:  María Del Mar Noblejas-López; Sara Morcillo-García; Cristina Nieto-Jiménez; Miriam Nuncia-Cantarero; Balázs Győrffy; Eva M Galan-Moya; Atanasio Pandiella; Alberto Ocaña
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.